Xylopropamine

Xylopropamine is a psychostimulant that is classified as a nootropic. It was developed in the 1950s and has been used for therapeutic purposes, but is not commonly used today due to its potential for abuse and addiction.

History

Xylopropamine was first synthesized in the 1950s by the pharmaceutical company Smith, Kline & French. It was marketed under the brand name Dexedrine as a treatment for narcolepsy, attention deficit hyperactivity disorder (ADHD), and obesity. However, due to its high potential for abuse and addiction, it is no longer commonly used.

Pharmacology

Xylopropamine acts as a norepinephrine-dopamine reuptake inhibitor (NDRI), which means it increases the levels of the neurotransmitters norepinephrine and dopamine in the brain by inhibiting their reuptake into neurons. This results in increased neuronal activity, which can lead to increased alertness, attention, and energy.

Side Effects

The side effects of xylopropamine can include insomnia, anxiety, agitation, and psychosis. Long-term use can lead to drug dependence and withdrawal symptoms upon cessation of use.

Legal Status

In the United States, xylopropamine is classified as a Schedule II controlled substance, which means it has a high potential for abuse and dependence, and its use is heavily regulated.

See Also

• Amphetamine
• Methamphetamine
• Phenethylamine

Xylopropamine Resources
Latest articles Most recent articles Ongoing trials	Wikipedia